Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 1, 2011
Grant Date -
Nov 5, 2009
app pub date -
Mar 17, 2009
filing date -
Jun 27, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to the identification of LPA as a ligand for the G-protein coupled receptors OSGPR114 and OSGPR78. The invention is directed to new methods for screening candidate drugs for their ability to modulate the activity of OSGPR114 or OSGPR78, and new pharmaceutical agents identified by these methods. It is also directed to the use of such agents in the manufacture of medicaments for the treatment of OSGPR114 or OSGPR78 mediated diseases, and methods of treating diseases such as cancers by administering to an individual a therapeutic amount of a modulator of OSGPR114 or OSGPR78 identified by these methods.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully